Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245 EUR | -0.08% | -2.62% | +15.68% |
06:14pm | Swiss Market Index Rises; Roche Shines on Promising Weight-loss Drug | MT |
05:16pm | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
Sales 2024 * | 60.07B 66.37B 61.03B 90.34B | Sales 2025 * | 63.62B 70.29B 64.64B 95.69B | Capitalization | 184B 203B 187B 276B |
---|---|---|---|---|---|
Net income 2024 * | 13.41B 14.82B 13.63B 20.17B | Net income 2025 * | 14.87B 16.43B 15.11B 22.37B | EV / Sales 2024 * | 3.29 x |
Net Debt 2024 * | 14.08B 15.55B 14.3B 21.17B | Net Debt 2025 * | 7.99B 8.83B 8.12B 12.02B | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
12.1
x | Employees | - |
Yield 2024 * |
4.27% | Yield 2025 * |
4.42% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -0.08% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 95-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.23% | 709B | |
+30.77% | 595B | |
-1.76% | 367B | |
+20.25% | 334B | |
+5.55% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
+9.11% | 171B | |
+0.12% | 163B |
- Stock Market
- Equities
- ROG Stock
- RHO Stock